32252776|t|MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion.
32252776|a|BACKGROUND: Chronic brain hypoperfusion (CBH) is closely related to Alzheimer's disease (AD) and vascular dementia (VaD). Meanwhile, synaptic pathology plays a prominent role in the initial stage of AD and VaD. However, whether and how CBH impairs presynaptic plasticity is currently unclear. METHODS: In the present study, we performed a battery of techniques, including primary neuronal culture, patch clamp, stereotaxic injection of the lentiviral vectors, morris water maze (MWM), dual luciferase reporter assay, FM1-43 fluorescence dye evaluation, qRT-PCR and western blot, to investigate the regulatory effect of miR-153 on hippocampal synaptic vesicle release both in vivo and in vitro. The CBH rat model was generated by bilateral common carotid artery ligation (2VO). RESULTS: Compared to sham rats, 2VO rats presented decreased field excitatory postsynaptic potential (fEPSP) amplitude and increased paired-pulse ratios (PPRs) in the CA3-CA1 pathway, as well as significantly decreased expression of multiple vesicle fusion-related proteins, including SNAP-25, VAMP-2, syntaxin-1A and synaptotagmin-1, in the hippocampi. The levels of microRNA-153 (miR-153) were upregulated in the hippocampi of rats following 2VO surgery, and in the plasma of dementia patients. The expression of the vesicle fusion-related proteins affected by 2VO was inhibited by miR-153, elevated by miR-153 inhibition, and unchanged by binding-site mutation or miR masks. FM1-43 fluorescence images showed that miR-153 blunted vesicle exocytosis, but this effect was prevented by either 2'-O-methyl antisense oligoribonucleotides to miR-153 (AMO-153) and miR-masking of the miR-153 binding site in the 3' untranslated region (3'UTR) of the Snap25, Vamp2, Stx1a and Syt1 genes. Overexpression of miR-153 by lentiviral vector-mediated miR-153 mimics (lenti-pre-miR-153) decreased the fEPSP amplitude and elevated the PPR in the rat hippocampus, whereas overexpression of the antisense molecule (lenti-AMO-153) reversed these changes triggered by 2VO. Furthermore, lenti-AMO-153 attenuated the cognitive decline of 2VO rats. CONCLUSIONS: Overexpression of miR-153 controls CBH-induced presynaptic vesicle release impairment by posttranscriptionally regulating the expression of four vesicle release-related proteins by targeting the 3'UTRs of the Stx1a, Snap25, Vamp2 and Syt1 genes. These findings identify a novel mechanism of presynaptic plasticity impairment during CBH, which may be a new drug target for prevention or treatment of AD and VaD. Video Abstract.
32252776	0	12	MicroRNA-153	Gene	100314038
32252776	90	109	brain hypoperfusion	Disease	MESH:D001927
32252776	131	150	brain hypoperfusion	Disease	MESH:D001927
32252776	152	155	CBH	Disease	MESH:D020208
32252776	179	198	Alzheimer's disease	Disease	MESH:D000544
32252776	200	202	AD	Disease	MESH:D000544
32252776	208	225	vascular dementia	Disease	MESH:D015140
32252776	227	230	VaD	Disease	MESH:D015140
32252776	310	312	AD	Disease	MESH:D000544
32252776	317	321	VaD.	Disease	MESH:D015140
32252776	347	350	CBH	Disease	MESH:D020208
32252776	730	737	miR-153	Gene	100314038
32252776	809	812	CBH	Disease	MESH:D020208
32252776	813	816	rat	Species	10116
32252776	882	885	2VO	Disease	
32252776	914	918	rats	Species	10116
32252776	920	923	2VO	Chemical	-
32252776	924	928	rats	Species	10116
32252776	1173	1180	SNAP-25	Gene	25012
32252776	1182	1188	VAMP-2	Gene	24803
32252776	1190	1201	syntaxin-1A	Gene	116470
32252776	1206	1221	synaptotagmin-1	Gene	25716
32252776	1256	1268	microRNA-153	Gene	100314038
32252776	1270	1277	miR-153	Gene	100314038
32252776	1317	1321	rats	Species	10116
32252776	1332	1335	2VO	Chemical	-
32252776	1366	1374	dementia	Disease	MESH:D003704
32252776	1375	1383	patients	Species	9606
32252776	1451	1454	2VO	Chemical	-
32252776	1472	1479	miR-153	Gene	100314038
32252776	1493	1500	miR-153	Gene	100314038
32252776	1605	1612	miR-153	Gene	100314038
32252776	1727	1734	miR-153	Gene	100314038
32252776	1768	1775	miR-153	Gene	100314038
32252776	1834	1840	Snap25	Gene	25012
32252776	1842	1847	Vamp2	Gene	24803
32252776	1849	1854	Stx1a	Gene	116470
32252776	1859	1863	Syt1	Gene	25716
32252776	1889	1896	miR-153	Gene	100314038
32252776	1927	1934	miR-153	Gene	100314038
32252776	1953	1960	miR-153	Gene	100314038
32252776	2020	2023	rat	Species	10116
32252776	2138	2141	2VO	Chemical	-
32252776	2185	2202	cognitive decline	Disease	MESH:D003072
32252776	2206	2209	2VO	Chemical	-
32252776	2210	2214	rats	Species	10116
32252776	2247	2254	miR-153	Gene	100314038
32252776	2264	2267	CBH	Disease	MESH:D020208
32252776	2438	2443	Stx1a	Gene	116470
32252776	2445	2451	Snap25	Gene	25012
32252776	2453	2458	Vamp2	Gene	24803
32252776	2463	2467	Syt1	Gene	25716
32252776	2561	2564	CBH	Disease	MESH:D020208
32252776	2628	2630	AD	Disease	MESH:D000544
32252776	2635	2639	VaD.	Disease	MESH:D015140
32252776	Association	MESH:D003704	100314038
32252776	Association	MESH:D001927	100314038

